DRESDEN, Germany, August. 11, 2021 /BioInformant/ — denovoMATRIX GmbH, a leading developer of technologies which enable high quality stem cell expansion, today announced the publication of patent application US2021/0145980, titled ‘non-covalently assembled matrix layer’. The patent is expected to provide broad protection for denovoMATRIX’ proprietary screenMATRIX and myMATRIX product lines in the Unites States.
This patent relates to the method of production of the company’s proprietary coating technology for enabling stem cell culture. ‘’We continue to see success developing a comprehensive global patent portfolio for our stem cell manufacturing technologies, and this latest publication further strengthens our IP position in the US cell therapy and clean meat markets’’ said Dr. Dejan Hušman, CEO of denovoMATRIX.
About denovoMATRIX GmbH
denovoMATRIX is an extracellular matrix engineering company that enables the acceleration of cell-based therapies and clean meat. The company leverages chemical synthesis, stem cell biology and design thinking to build a platform of biomaterials which address major life science challenges. By providing both cell-based therapy and clean meat companies with solutions, denovoMATRIX is at the forefront of innovation in high-impact biomaterials.
For more information, visit: https://www.denovomatrix.com/
Contact
denovoMATRIX GmbH
Dr. Dejan Hušman
Tatzberg 47/49
01307 Dresden
mail@denovomatrix.com